Microbot Medical Inc. (MBOT)

Last Closing Price: 2.68 (2025-05-29)

Company Description

Microbot Medical Inc. is engaged in the research, design, development and commercialization of micro-robotics assisted medical technologies. Its product candidate includes the Self Cleaning Shunt for the treatment of hydrocephalus and Normal Pressure Hydrocephalus and TipCAT, a self-propelling, semi-disposable endoscope which is being developed initially for use in colonoscopy procedures. Microbot Medical Inc., formerly known as Stemcells, Inc., is headquartered in Hingham, MA.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) --
Net Income (Most Recent Fiscal Year) $-11.44M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 3.22
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) --
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) -110.27%
Return on Assets (Trailing 12 Months) -94.20%
Current Ratio (Most Recent Fiscal Quarter) 16.19
Quick Ratio (Most Recent Fiscal Quarter) 16.19
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $0.80
Earnings per Share (Most Recent Fiscal Quarter) $-0.08
Earnings per Share (Most Recent Fiscal Year) $-0.73
Diluted Earnings per Share (Trailing 12 Months) $-0.65
Stock
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Common Shares Outstanding 36.38M
Free Float 34.65M
Market Capitalization $97.49M
Average Volume (Last 20 Days) 1.71M
Beta (Past 60 Months) 1.15
Percentage Held By Insiders (Latest Annual Proxy Report) 4.74%
Percentage Held By Institutions (Latest 13F Reports) 16.30%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%